Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS

Minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) are glomerulopathies associated with nephrotic syndrome. Primary forms of these diseases are treated with various regimes of immunosuppression. Frequently relapsing or glucocorticoid-dependent courses remain challenging. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Osterholt, Thomas, Todorova, Polina, Kühne, Lucas, Ehren, Rasmus, Weber, Lutz Thorsten, Grundmann, Franziska, Benzing, Thomas, Brinkkötter, Paul Thomas, Völker, Linus Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141841/
https://www.ncbi.nlm.nih.gov/pubmed/37117201
http://dx.doi.org/10.1038/s41598-023-32576-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141841/
https://www.ncbi.nlm.nih.gov/pubmed/37117201
http://dx.doi.org/10.1038/s41598-023-32576-7

Ejemplares similares